Michael Rauh

Dr. Michael Rauh

Assistant Professor & Attending Hematopathologist, Queen's University, Kingston


Diagnosis of myeloid cancers requires invasive bone marrow sampling and is reliant on subjective microscopy, especially for MDS. My research aims to develop novel, blood-based, somatic mutation and digital gene expression assays to improve myeloid cancer diagnosis, risk and treatment stratification. The sensitivity of these assays enable us to detect pre-cancerous, clonal hematopoiesis (CHIP) and we aim to elucidate early clone-immune environment interactions to inform novel therapeutic directions.

Funded Projects

Extracellular vesicles in aging and clonal hematopoiesis »

The relationship between immunotherapy and clonal hematopoiesis of indeterminant potential (CHIP) in patients with advanced melanoma »

Path2MyDx: Personalized Molecular Pathology for Myeloid Cancer Diagnosis »

Research Specialties

Research Interests

  • Hematological
  • Molecular Pathology

Contact for Collaboration

Queen's University
99 University Avenue
Kingston, ON, K7L 3N6
Pathologists and Researchers who are interested in being part of the OMPRN: